The role of clinical guidelines in developing quality control tools for pharmacotherapy
https://doi.org/10.20996/1819-6446-2025-3165
Abstract
International experience in implementing specialized programs into clinical practice — programs that assist healthcare professionals in applying evidence-based treatment outlined in clinical guidelines (CG) — confirms the effectiveness of this approach. It demonstrates significant, sustained improvement in healthcare quality, improved treatment outcomes, and reduced adverse events. An integral part of such programs are special tools (indices, checklists, scales) that enable evaluation of treatment quality, including pharmacotherapy (PhT), and monitoring adherence to CG. Since 2018, in the Russian Federation, CG have been legally recognized as regulatory documents governing the provision of medical care. Since January 2025, a phased transition to mandatory compliance with CG provision across all levels of healthcare has been completed. Given that PhT is the most common type of medical intervention, there is an increasing need to develop and implement quality indicators for PhT. These indicators would assess alignment of prescribed treatments with CGs and must be integrated into clinical practice. The article discusses international and domestic PhT quality control tools that have been developed and tested to date. The use of these indices as independent tools for quality control systems or as part of comprehensive electronic programs for medical decision- making and self-examination of prescriptions by attending physicians seems to be a very promising area in the field of healthcare and requires further study, development, and implementation into practice.
Keywords
About the Authors
Yu. V. LukinaRussian Federation
Yulia V. Lukina
Moscow
N. P. Kutishenko
Russian Federation
Natalia P. Kutishenko
Moscow
S. Yu. Martsevich
Russian Federation
Sergey Yu. Martsevich
Moscow
O. M. Drapkina
Russian Federation
Oksana M. Drapkina
Moscow
References
1. Lukina YV, Kutishenko NP, Martsevich SY, Drapkina OM. Problematic issues and the development of classifications of the main parameters of quality and adherence to pharmacotherapy. Part III: the quality of drug therapy. Cardiovascular therapy and prevention. 2024;23(12):4268 (In Russ.) DOI: 10.15829/1728-8800-2024-4268.
2. Khafizyanova RH, Burykin IM, Aleeva GN. The role of indicators in assessing the quality of pharmacotherapy and medical care. Bulletin of St. Petersburg State University. Medicine. 2011;11(4):103-11 (In Russ.)
3. Martsevich SY, Kutishenko NP, Lukina YV, et al. Main Approaches to Assessing the Quality of Drug Therapy in Cardiology. Rational Pharmacotherapy in Cardiology. 2018;14(4):558-66 (In Russ.) DOI: 10.20996/1819-6446-2018-14-4-558-566.
4. Smaha LA; American Heart Association. The American Heart Association Get With The Guidelines program. Am Heart J. 2004;148(5 Suppl):S46-8. DOI: 10.1016/j.ahj.2004.09.015.
5. Ormseth CH, Sheth KN, Saver JL, et al. The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke Vasc Neurol. 2017;2(2):94-105. DOI: 10.1136/svn-2017-000092.
6. LaBresh KA, Ellrodt AG, Gliklich R, et al. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004;164(2):203-9. DOI: 10.1001/archinte.164.2.203.
7. Xian Y, Li S, Jiang T, et al. Twenty Years of Sustained Improvement in Quality of Care and Outcomes for Patients Hospitalized With Stroke or Transient Ischemic Attack: Data From The Get With The Guidelines-Stroke Program. Stroke. 2024;55(11):2599-610. DOI: 10.1161/STROKEAHA.124.048174.
8. Krisch L, Mahlknecht A, Bauer U, et al. The challenge to define a relevant change in medication appropriateness index score in older adults — An approach. Br J Clin Pharmacol. 2020;86(2):398-9. DOI: 10.1111/bcp.14167.
9. Hanlon JT, Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30(11):893-900. DOI: 10.1007/s40266-013-0118-4.
10. Sychev DA, Sosnovsky EE, Orekhov RE, Bordovsky SP. Contemporary methods of dealing polypharmacy in elderly and senile patients. Siberian Medical Review. 2016;(2):13-21 (In Russ.)
11. Komajda M, Cowie MR, Tavazzi L, et al. QUALIFY Investigators. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2017;19(11):1414-23. DOI: 10.1002/ejhf.887.
12. Zyryanov SK, Fitilev SB, Vozzhaev AV, et al. Implementation of the concept of standard operating procedures into primary care practice: utopia or urgent need? Kachestvennaya klinicheskaya praktika = Good Clinical Practice. 2020;(3):75-84 (In Russ.) DOI: 10.37489/2588-0519-2020-3-75-84.
13. Suvorov AY, Martsevich SY, Kutishenko NP, et al. The way of assessing the adherence to modern drug therapy clinical guidelines aimed at reducing the risk of recurrent stroke (according to the LIS-2 register). Rational Pharmacotherapy in Cardiology. 2015;11(1):45-52 (In Russ.) DOI: 10.20996/1819-6446-2015-11-1-45-52.
14. Lukina YuV, Kutishenko NP, Martsevich SYu, et al. Novel approaches to the comprehensive assessment of the quality and adherence to pharmacotherapy and its use in cardiovascular patients. Cardiovascular Therapy and Prevention. 2023;22(1):3522 (In Russ.) DOI: 10.15829/1728-8800-2023-3522.
Supplementary files
Review
For citations:
Lukina Yu.V., Kutishenko N.P., Martsevich S.Yu., Drapkina O.M. The role of clinical guidelines in developing quality control tools for pharmacotherapy. Rational Pharmacotherapy in Cardiology. 2025;21(1):61-64. (In Russ.) https://doi.org/10.20996/1819-6446-2025-3165